Anti-MIA2/ CTAGE5/ MEA6 functional antibody

Anti-MIA2/ CTAGE5/ MEA6 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to MIA2/MIA2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0131-Ab-1/ GM-Tg-hg-SE0131-Ab-2Anti-Human MIA2 monoclonal antibodyHuman
GM-Tg-rg-SE0131-Ab-1/ GM-Tg-rg-SE0131-Ab-2Anti-Rat MIA2 monoclonal antibodyRat
GM-Tg-mg-SE0131-Ab-1/ GM-Tg-mg-SE0131-Ab-2Anti-Mouse MIA2 monoclonal antibodyMouse
GM-Tg-cynog-SE0131-Ab-1/ GM-Tg-cynog-SE0131-Ab-2Anti-Cynomolgus/ Rhesus macaque MIA2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0131-Ab-1/ GM-Tg-felg-SE0131-Ab-2Anti-Feline MIA2 monoclonal antibodyFeline
GM-Tg-cang-SE0131-Ab-1/ GM-Tg-cang-SE0131-Ab-2Anti-Canine MIA2 monoclonal antibodyCanine
GM-Tg-bovg-SE0131-Ab-1/ GM-Tg-bovg-SE0131-Ab-2Anti-Bovine MIA2 monoclonal antibodyBovine
GM-Tg-equg-SE0131-Ab-1/ GM-Tg-equg-SE0131-Ab-2Anti-Equine MIA2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0131-Ab-1/ GM-Tg-hg-SE0131-Ab-2; GM-Tg-rg-SE0131-Ab-1/ GM-Tg-rg-SE0131-Ab-2;
GM-Tg-mg-SE0131-Ab-1/ GM-Tg-mg-SE0131-Ab-2; GM-Tg-cynog-SE0131-Ab-1/ GM-Tg-cynog-SE0131-Ab-2;
GM-Tg-felg-SE0131-Ab-1/ GM-Tg-felg-SE0131-Ab-2; GM-Tg-cang-SE0131-Ab-1/ GM-Tg-cang-SE0131-Ab-2;
GM-Tg-bovg-SE0131-Ab-1/ GM-Tg-bovg-SE0131-Ab-2; GM-Tg-equg-SE0131-Ab-1/ GM-Tg-equg-SE0131-Ab-2
Products NameAnti-MIA2 monoclonal antibody
Formatmab
Target NameMIA2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MIA2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0131-Ag-1Recombinant multi-species MIA2/ CTAGE5/ MEA6 protein


    Target information

    Target IDGM-SE0131
    Target NameMIA2
    Gene ID4253,338320,100912115,699511,480298,101088002,513132,100051101
    Gene Symbol and SynonymsCTAGE5,D12Bwg0579e,MEA6,MGEA,MGEA11,MGEA6,MIA2,TALI
    Uniprot AccessionQ96PC5
    Uniprot Entry NameMIA2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseBreast Cancer
    Gene EnsemblENSG00000150527
    Target ClassificationN/A

    The target: MIA2, gene name: MIA2, also named as CTAGE5, MEA6, MGEA, MGEA11, MGEA6, TALI. This gene encodes s receptor in the endoplasmic reticulum, which plays a role in the export of large pre-chylomicrons and pre-very low density lipoproteins (pre-VLDLs). Three major classes of transcripts are generated from this gene- melanoma inhibitory activity 2-specific transcripts, cTAGE family member 5-specific transcripts and transcripts that include exons from both these transcript species (TANGO1-like or TALI). Additionally, alternative splicing in these transcripts results in multiple transcript variants encoding multiple isoforms. [provided by RefSeq, Sep 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.